|
|
|
1-10 employees
View all
|
|
Pharmaceuticals
|
|
105 Union Avenue, Cresskill, NJ 07626, US
|
|
Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery.
Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.
|
Vascular Therapies Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Vascular Therapies email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Vascular Therapies customer service number in your country click here to find.
John Mcdermott is the CEO of Vascular Therapies. To contact John Mcdermott email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.